Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model
Takehisa Nakanishi(Mie University), Keiichi Yamanaka(Mie University), Ayaka Ichikawa(Mie University), Mai Nishimura(Mie University), Makoto Kondo(Mie University), Masatoshi Watanabe(Mie University), Yoichiro Iwakura(Tokyo University of Science), Masako Ichishi(Mie University), Shohei Iida(Mie University), Yoshiaki Matsushima(Mie University)
Cited by 2
Related Papers
Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion
|The Journal of Experimental Medicine|1998|615
IL-1 plays an important role in the bone metabolism under physiological conditions
|International Immunology|2010|222
Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology
|The Journal of Experimental Medicine|2011|192
IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vγ6+γδ T cells
|Nature Communications|2015|118
Systemic Dermatitis Model Mice Exhibit Atrophy of Visceral Adipose Tissue and Increase Stromal Cells via Skin-Derived Inflammatory Cytokines
|International Journal of Molecular Sciences|2020|15